Goldman Sachs Downgrades MoonLake to Sell, Raises Price Target to $10
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 15 2026
0mins
Source: Benzinga
- MoonLake Downgrade: Goldman Sachs analyst Richard Law downgraded MoonLake Immunotherapeutics from Neutral to Sell while raising the price target from $8 to $10, indicating cautious sentiment despite the current share price of $17.41.
- Leslie’s Inc Rating Change: Morgan Stanley analyst Simeon Gutman downgraded Leslie’s Inc from Equal-Weight to Underweight, cutting the price target from $3.5 to $1.5, reflecting concerns about the company's future profitability with shares currently at $1.54.
- Rocket Lab Rating Adjustment: Keybanc analyst Michael Leshock downgraded Rocket Lab Corp from Overweight to Sector Weight, indicating a conservative outlook on its market performance, with shares priced at $91.80.
- Albertsons Downgrade: Morgan Stanley analyst Simeon Gutman downgraded Albertsons Companies Inc from Equal-Weight to Underweight, lowering the price target from $20 to $14, suggesting a pessimistic view on future growth as shares are currently at $17.71.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like ACI with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on ACI
Wall Street analysts forecast ACI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACI is 22.27 USD with a low forecast of 17.00 USD and a high forecast of 29.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
16 Analyst Rating
10 Buy
5 Hold
1 Sell
Moderate Buy
Current: 16.690
Low
17.00
Averages
22.27
High
29.00
Current: 16.690
Low
17.00
Averages
22.27
High
29.00
About ACI
Albertsons Companies, Inc. is a food and drug retailer in the United States. The Company is engaged in the operation of food and drug retail stores that offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel and other items and services in its stores or through digital channels. It operates approximately 2,257 retail stores with 1,720 in-store pharmacies, 405 associated fuel centers, 22 dedicated distribution centers and 19 manufacturing facilities. The Company operates stores across 35 states and the District of Columbia under 22 banners, including Albertsons, Safeway, Vons, Jewel-Osco, Shaw's, ACME, Tom Thumb, Randalls, United Supermarkets, Pavilions, Star Market, Haggen, Carrs, Kings Food Markets and Balducci's Food Lovers Market. Its own brands include Signature SELECT, Open Nature, Lucerne, Waterfront BISTRO, Signature Reserve and Value Corner, among others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Amazon Adjusts Grocery Strategy, Shares Rise Over 1%
- Amazon's Strategic Shift: Amazon's decision to close its Fresh and Go brick-and-mortar stores marks a significant pivot in its grocery strategy, resulting in a more than 1% rise in its stock during midday trading, while rivals Kroger and Albertsons saw declines of about 3%.
- Micron's Expansion Investment: Micron Technology has commenced construction of an advanced wafer fabrication facility at its existing NAND manufacturing plant in Singapore, with a planned investment of approximately $24 billion over the next decade, leading to a roughly 5% increase in its stock price.
- Sysco's Earnings Beat: Sysco reported earnings that exceeded expectations, with a fiscal second-quarter EPS of $0.99 compared to the $0.98 anticipated by analysts, resulting in a 9% stock price increase and an updated full-year guidance at the higher end of $4.50 to $4.60 per share.
- UnitedHealth Stock Decline: Shares of UnitedHealth and Humana dropped about 20% after the Centers for Medicare & Medicaid Services proposed a mere 0.09% increase in 2027 Medicare Advantage payment rates, significantly lower than the expected 4% to 6% rise.
Continue Reading
Albertsons Companies Prices $1.2 Billion Senior Notes Offering to Redeem Debt
- Debt Restructuring Plan: Albertsons announced the pricing of $1.2 billion in 5.625% senior notes, expected to close on February 2, 2026, which will help optimize the company's capital structure and reduce future interest expenses.
- Clear Use of Proceeds: The proceeds from this offering will be used to redeem $1.35 billion of 4.625% senior notes and $750 million of 5.875% senior notes, which is expected to significantly alleviate the company's debt burden and improve financial flexibility.
- Positive Market Reaction: Following the announcement, Albertsons' stock rose 0.11% in after-hours trading to $17.2, indicating investor approval of the company's debt management strategy.
- Optimistic Long-Term Outlook: This debt restructuring not only allows Albertsons to lower interest expenses but also provides more financial room for future expansion and investments, strengthening its position in the highly competitive grocery market.
Continue Reading